Good morning :)
Place Order
Add to Watchlist

Medico Intercontinental Ltd

MIL

Medico Intercontinental Ltd

MIL
Health CarePharmaceuticals
SmallcapWith a market cap of ₹55 cr, stock is ranked 3,513
High RiskStock is 3.44x as volatile as Nifty
55.150.00% (+0.00)
55.150.00% (+0.00)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹55 cr, stock is ranked 3,513
High RiskStock is 3.44x as volatile as Nifty

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹55 cr, stock is ranked 3,513
High RiskStock is 3.44x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
11.611.220.18%
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.706.650.52%

Forecast & Ratings

Detailed Forecast 
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Medico Intercontinental Ltd is engaged in the trading of pharmaceutical products

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 47.41%, vs industry avg of 9.04%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0% to 0.02%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 40.1%, vs industry avg of 15.28%

Loading...

Financial YearFY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue0.3910.3182.0169.9274.5776.7471.7685.82
Raw Materialssubtract0.219.5375.1858.0559.6163.3056.4377.99
Power & Fuel Costsubtract0.000.000.060.060.170.060.07
Employee Costsubtract0.060.033.011.811.752.472.97
Selling & Administrative Expensessubtract0.070.324.915.316.245.957.42
Operating & Other expensessubtract-0.00-0.58-5.55-0.261.48-0.81-1.35
Depreciation/Amortizationsubtract0.000.000.100.140.210.200.290.44
Interest & Other Itemssubtract0.000.011.101.280.880.620.500.75
Taxes & Other Itemssubtract0.020.270.840.951.131.341.491.89
EPS0.092.257.267.949.545.453.944.75
DPS0.000.000.000.000.000.100.100.00
Payout ratio0.000.000.000.000.000.020.030.00

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Medico Intercontinental Ltd14.001.220.18%
Sun Pharmaceutical Industries Ltd45.466.490.74%
Mankind Pharma Ltd64.6712.92
Cipla Ltd28.924.450.88%

Price Comparison

Compare MIL with any stock or ETF
Compare MIL with any stock or ETF
MIL
Loading...

Shareholdings

Promoter Holdings Trend

Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding55.08%0.00%0.00%0.00%44.92%

Dec 2023

Mar 2024

Jun 2024

Sep 2024

Shareholding History

JunSepDec '23MarJunSep0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Hmm, looks like there hasn't been any net deal activity in the last 6 months

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJun 23, 2023

Final
Final | Div/Share: ₹0.10

Dividend/Share

0.10

Ex DateEx Date

Jun 23, 2023

News & Opinions
Earnings
Medico Intercontinental consolidated net profit rises 87.36% in the September 2024 quarter

Net profit of Medico Intercontinental rose 87.36% to Rs 1.63 crore in the quarter ended September 2024 as against Rs 0.87 crore during the previous quarter ended September 2023. Sales rose 117.52% to Rs 37.24 crore in the quarter ended September 2024 as against Rs 17.12 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales37.2417.12 118 OPM %7.497.71 - PBDT2.551.30 96 PBT2.341.23 90 NP1.630.87 87 Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Medico Intercontinental standalone net profit rises 106.25% in the September 2024 quarter

Net profit of Medico Intercontinental rose 106.25% to Rs 0.99 crore in the quarter ended September 2024 as against Rs 0.48 crore during the previous quarter ended September 2023. Sales rose 195.01% to Rs 28.94 crore in the quarter ended September 2024 as against Rs 9.81 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales28.949.81 195 OPM %5.814.99 - PBDT1.600.71 125 PBT1.450.66 120 NP0.990.48 106 Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Medico Intercontinental to table results

Medico Intercontinental will hold a meeting of the Board of Directors of the Company on 14 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Medico Intercontinental to convene AGM

Medico Intercontinental announced that the Annual General Meeting (AGM) of the company will be held on 27 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Medico Intercontinental consolidated net profit rises 5.88% in the June 2024 quarter

Net profit of Medico Intercontinental rose 5.88% to Rs 1.08 crore in the quarter ended June 2024 as against Rs 1.02 crore during the previous quarter ended June 2023. Sales declined 24.92% to Rs 18.23 crore in the quarter ended June 2024 as against Rs 24.28 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales18.2324.28 -25 OPM %8.896.10 - PBDT1.571.45 8 PBT1.491.38 8 NP1.081.02 6 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Medico Intercontinental to conduct board meeting

Medico Intercontinental will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live

Medico Intercontinental consolidated net profit rises 52.63% in the March 2022 quarter

2 years agoBusiness Standard

Medico Intercontinental consolidated net profit rises 8.82% in the September 2021 quarter

3 years agoBusiness Standard

Medico Intercontinental consolidated net profit declines 1.72% in the March 2021 quarter

3 years agoBusiness Standard